Cadrenal Therapeutics, INC. (CVKD) SEC Filings — 2024
24 SEC filings for Cadrenal Therapeutics, INC. (CVKD) in 2024.
Filings
- Cadrenal Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Cadrenal Therapeutics Files Q3 2024 10-Q Report — 10-Q · Nov 7, 2024
- Cadrenal Therapeutics Files 8-K: Agreements, Equity Sales, and More — 8-K · Nov 4, 2024
- Cadrenal Therapeutics Files 8-K Report — 8-K · Oct 24, 2024
- Cadrenal Therapeutics, INC. SC 13G Filing — SC 13G · Oct 4, 2024
- Cadrenal Therapeutics Files 8-K — 8-K · Sep 25, 2024
- Cadrenal Therapeutics Faces Delisting Concerns — 8-K · Sep 5, 2024
- Cadrenal Therapeutics Acquires Subsidiary Cadrenal Biologics — 8-K · Aug 20, 2024
- Cadrenal Therapeutics Files 8-K — 8-K · Aug 16, 2024
- Cadrenal Therapeutics Files 8-K with Financial Updates — 8-K · Aug 8, 2024
- Cadrenal Therapeutics Files Q2 2024 10-Q Report — 10-Q · Aug 7, 2024
- Cadrenal Therapeutics Files 8-K Report — 8-K · Aug 6, 2024
- Cadrenal Therapeutics Appoints New CMO, Elects Directors — 8-K · Jul 31, 2024
- Cadrenal Therapeutics Files Proxy Materials — DEFA14A · Jun 12, 2024
- Cadrenal Therapeutics Files Definitive Proxy Statement — DEF 14A · Jun 11, 2024
- Cadrenal Therapeutics, Inc. Files 10-Q for Period Ended March 31, 2024 — 10-Q · May 9, 2024
- Cadrenal Therapeutics Files 8-K with Financials — 8-K · Apr 9, 2024
- Cadrenal Therapeutics Enters Material Definitive Agreement — 8-K · Mar 12, 2024
- Cadrenal Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 11, 2024
- Cadrenal Therapeutics Faces Delisting Notice — 8-K · Mar 5, 2024
- Cadrenal Therapeutics Amends 8-K on Delisting Notice — 8-K/A · Feb 15, 2024
- Cadrenal Therapeutics, INC. SC 13G Filing — SC 13G · Feb 14, 2024
- Cadrenal Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Cadrenal Therapeutics (CVKD) Confirms Nasdaq Listing in 8-K Filing — 8-K · Feb 12, 2024